Status | Study |
Active, not recruiting |
Study Name: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer Condition: Adenocarcinoma Colorectal Cancer Ovarian Cancer Date: 2004-07-23 Interventions: Biological: PANVAC-V A recombi |
Completed |
Study Name: Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma Condition: Melanoma (Skin) Date: 2004-06-10 Interventions: Biological: aldesleukin Biological: filgra |
Terminated |
Study Name: Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy Condition: Bladder Adenocarcinoma Bladder Squamous Cell Carcinoma Bla Date: 2003-11-04 Interventions: Biological: Recombinant Fowlpox-TRICOM Vaccine |
Completed |
Study Name: Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma Condition: Melanoma (Skin) Date: 2003-02-05 Interventions: Biological: aldesleukin Biological: recomb |
Completed |
Study Name: Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer Condition: Breast Cancer Date: 2003-01-24 Interventions: Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine |
Completed |
Study Name: Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer Condition: Adenocarcinoma of the Colon Adenocarcinoma of the Gallbladder Date: 2002-01-04 Interventions: Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine |
Completed |
Study Name: Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer Condition: Breast Cancer Colorectal Cancer Gallbladder Cancer Date: 2001-12-07 Interventions: Biological: TRICOM-CEA(6D) dendritic cells loaded with TRICOM-CEA(6D) |
Completed |
Study Name: Vaccine Therapy in Treating Patients With Metastatic Melanoma Condition: Melanoma (Skin) Date: 2001-07-11 Interventions: Biological: aldesleukin Biological: fowlpo |
Completed |
Study Name: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma Condition: Melanoma (Skin) Date: 2001-07-11 Interventions: Biological: aldesleukin Biological: fowlpo |
Completed |
Study Name: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma Condition: Melanoma (Skin) Date: 2001-07-11 Interventions: Biological: aldesleukin Biological: fowlpo |